rdf:type |
|
lifeskim:mentions |
umls-concept:C0004482,
umls-concept:C0013216,
umls-concept:C0025677,
umls-concept:C0032952,
umls-concept:C0751356,
umls-concept:C0871261,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C1707455,
umls-concept:C2698872,
umls-concept:C2911692
|
pubmed:issue |
4
|
pubmed:dateCreated |
1993-5-20
|
pubmed:abstractText |
To identify factors associated with responses to treatment with prednisone, methotrexate, or azathioprine in patients with idiopathic inflammatory myopathy, and to compare the efficacy of these drugs.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0002-9343
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
94
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
379-87
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:8386437-Adult,
pubmed-meshheading:8386437-Autoantibodies,
pubmed-meshheading:8386437-Azathioprine,
pubmed-meshheading:8386437-Cohort Studies,
pubmed-meshheading:8386437-Female,
pubmed-meshheading:8386437-Humans,
pubmed-meshheading:8386437-Inclusion Bodies,
pubmed-meshheading:8386437-Logistic Models,
pubmed-meshheading:8386437-Male,
pubmed-meshheading:8386437-Methotrexate,
pubmed-meshheading:8386437-Myositis,
pubmed-meshheading:8386437-Prednisone,
pubmed-meshheading:8386437-Prognosis,
pubmed-meshheading:8386437-Retrospective Studies,
pubmed-meshheading:8386437-Sex Factors,
pubmed-meshheading:8386437-Time Factors,
pubmed-meshheading:8386437-Treatment Outcome
|
pubmed:year |
1993
|
pubmed:articleTitle |
Drug therapy of the idiopathic inflammatory myopathies: predictors of response to prednisone, azathioprine, and methotrexate and a comparison of their efficacy.
|
pubmed:affiliation |
National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, U.S. Gov't, P.H.S.
|